Tyra Bioscience, Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Tyra Bioscience, Inc
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company’s in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
Frequently asked questions
To buy Tyra Bioscience, Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Tyra Bioscience, Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Tyra Bioscience, Inc is TYRA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Tyra Bioscience, Inc has its primary listing on NASDAQ. You can trade Tyra Bioscience, Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Tyra Bioscience, Inc is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Tyra Bioscience, Inc as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Tyra Bioscience, Inc.